Ceratitis capitata is an important pest of citrus in Greece, also causing severe damage to other fruits. Its control has been based on organophosphates for many decades, but recently there has been a switch to pyrethroids. In the present study, the resistance status to deltamethrin and spinosad in 27 C. capitata samples from various hosts and regions of Greece was examined with toxicity bioassays. The bioassays did not reveal significant levels of resistance in either of the two insecticides. All but one of the samples tested with deltamethrin showed a significantly higher LD50 than the susceptible strain (LS) but the resistance factor (RF) values were low (1.2–4.6). In support of this, no significant overexpression of the CYP6A51 gene (associated with pyrethroid resistance in other studies) was detected in the samples examined compared to the LS, indicating the absence of incipient pyrethroid resistance. Lower between-sample variation was observed in the response to spinosad compared to deltametrin; CV for LD50 values: 19.4 vs. 40.0%, respectively, RF values: 1.1–2.4 and 23 out of the 27 field samples had LD50 significantly higher than the LS. This might suggest lower genetic variation related to resistance where selection can act. Our results suggest that deltamethrin can effectively control C. capitata in Greece and spinosad may be a valuable alternative, once registered for the control of this pest in Greece. However, continuous monitoring is important given that P450-mediated metabolic resistance has been demonstrated for C. capitata populations in the Mediterranean basin.
Journal of Pest Science – Springer Journals
Published: Aug 31, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera